Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Mexican (IPC) Drug Retail Industry Analysis

UpdatedFeb 21, 2026
DataAggregated Company Financials
Companies1
  • 7D2.0%
  • 3M1.3%
  • 1Y-5.0%
  • YTDn/a

Over the last 7 days, the Drug Retail industry has dropped 2.1%, driven by pullbacks from every company within the industry. However, the industry is down 7.8% over the past year. Looking forward, earnings are forecast to grow by 14% annually.

Industry Valuation and Performance

Has the Mexican Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 21 Feb 2026Mex$51.7bMex$129.2bMex$5.0b10.4x10.4x0.4x
Mon, 19 Jan 2026Mex$61.3bMex$147.6bMex$5.2b28.4x11.8x0.4x
Wed, 17 Dec 2025Mex$63.1bMex$147.6bMex$5.2b28.5x12.2x0.4x
Fri, 14 Nov 2025Mex$63.7bMex$147.6bMex$5.2b28.5x12.3x0.4x
Sun, 12 Oct 2025Mex$64.1bMex$143.7bMex$5.2b31.6x12.3x0.4x
Tue, 09 Sep 2025Mex$61.0bMex$143.7bMex$5.2b31.3x11.7x0.4x
Thu, 07 Aug 2025Mex$62.9bMex$143.7bMex$5.2b31.5x12x0.4x
Sat, 05 Jul 2025Mex$63.0bMex$140.1bMex$5.1b38.3x12.3x0.4x
Mon, 02 Jun 2025Mex$64.5bMex$140.1bMex$5.1b38.5x12.6x0.5x
Wed, 30 Apr 2025Mex$58.5bMex$137.9bMex$5.0b45.3x11.7x0.4x
Fri, 28 Mar 2025Mex$61.1bMex$137.9bMex$5.0b45.3x12.2x0.4x
Sun, 23 Feb 2025Mex$63.5bMex$135.4bMex$5.1b25.8x12.4x0.5x
Tue, 21 Jan 2025Mex$62.0bMex$135.4bMex$5.1b26.1x12.1x0.5x
Thu, 19 Dec 2024Mex$66.8bMex$135.4bMex$5.1b33.8x13.2x0.5x
Sat, 16 Nov 2024Mex$88.2bMex$135.4bMex$5.1b33.4x17.4x0.7x
Mon, 14 Oct 2024Mex$94.6bMex$133.0bMex$5.1b34.1x18.4x0.7x
Wed, 11 Sep 2024Mex$101.3bMex$133.0bMex$5.1b34.8x19.7x0.8x
Fri, 09 Aug 2024Mex$99.3bMex$132.9bMex$5.2b31.3x19.2x0.7x
Sun, 07 Jul 2024Mex$92.6bMex$112.9bMex$4.8b19.3x19.3x0.8x
Tue, 04 Jun 2024Mex$92.3bMex$130.5bMex$5.0b29.7x18.5x0.7x
Thu, 02 May 2024Mex$82.0bMex$126.5bMex$4.7b25.3x17.4x0.6x
Sat, 30 Mar 2024Mex$72.7bMex$124.1bMex$4.2b25.3x17.2x0.6x
Mon, 26 Feb 2024Mex$66.8bMex$124.1bMex$4.2b24.5x15.8x0.5x
Wed, 24 Jan 2024Mex$57.1bMex$124.1bMex$4.2b23.3x13.5x0.5x
Fri, 22 Dec 2023Mex$56.2bMex$124.1bMex$4.2b23.2x13.3x0.5x
Sun, 19 Nov 2023Mex$52.2bMex$124.1bMex$4.2b22.6x12.3x0.4x
Tue, 17 Oct 2023Mex$53.3bMex$121.1bMex$3.9b22x13.7x0.4x
Thu, 14 Sep 2023Mex$53.5bMex$121.1bMex$3.9b21.2x13.8x0.4x
Sat, 12 Aug 2023Mex$50.2bMex$121.1bMex$3.9b18.5x12.9x0.4x
Mon, 10 Jul 2023Mex$50.3bMex$117.4bMex$3.5b24.1x14.4x0.4x
Wed, 07 Jun 2023Mex$51.2bMex$117.4bMex$3.5b21.1x14.7x0.4x
Fri, 05 May 2023Mex$48.4bMex$97.9bMex$3.2b15.3x15.3x0.5x
Sun, 02 Apr 2023Mex$46.6bMex$97.9bMex$3.2b14.7x14.7x0.5x
Tue, 28 Feb 2023Mex$33.9bMex$93.6bMex$3.0b11.2x11.2x0.4x
Price to Earnings Ratio

11.2x


Total Market Cap: Mex$33.9bTotal Earnings: Mex$3.0bTotal Revenue: Mex$93.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Mexican Drug Retail Industry Price to Earnings3Y Average 14.3x202420252026
Current Industry PE
    There is only one company in the Mexican Drug Retail industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Drug Retail industry have grown 18% per year over the last three years.
  • Revenues for these companies have grown 11% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Mexican Drug Retail compare with similar industries?

MX Market-0.18%
Consumer Staples-1.35%
Food and Staples Retail-1.15%
Drug Retail2.01%
Big Box Super Stores-0.88%
Food Retail-4.03%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
FRAGUA B Corporativo Fragua. deMex$536.812.0%
+Mex$1.0b		-5.0%PE10.4x

Latest News

FRAGUA B
Mex$536.81
Corporativo Fragua. de
7D
2.0%
1Y
-5.0%

Is Corporativo Fragua. de (BMV:FRAGUAB) A Risky Investment?

Dec 20
Is Corporativo Fragua. de (BMV:FRAGUAB) A Risky Investment?